MarketPeel
Insider Trading Intelligence
AM

Adam Morgan

HRTX
DIRECTOR · HERON THERAPEUTICS, INC. /DE/ · CIK 0001964335
FILING MIX · LIFETIME100%/0%
BUYS
14
SELLS
0
TOTAL VALUE
$13.29M
COMPANIES
2
ACTIVE SINCE
Feb 2023
HOLDINGS NOW
1,312,237
AVG SELL PX
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Adam Morgan, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%+6.20%+0.96%+5.24%+2.66%
14d5+100.00%+12.89%+0.40%+12.49%+9.91%
30d5+60.00%+21.28%+0.13%+21.14%+28.20%
60d5+20.00%+7.61%+2.19%+5.42%-5.01%
90d5+20.00%-23.78%+0.76%-24.54%-21.87%
180d5+40.00%+22.92%+6.26%+16.65%-7.69%
1y5(2 pending)+66.67%+68.79%+22.77%+46.02%+112.40%
2y5(2 pending)+66.67%-4.65%+41.82%-46.47%-3.20%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HRTX · 123,737 shares · as of Jan 30, 2026
02,188,3234,376,6456,564,9688,753,290202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 14 buys / 0 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
53,960123,737Jan 30, 2026Feb 3, 2026View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
70,012$15.00$1.05M70,012Aug 8, 2025Aug 12, 2025View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
1,766,546$1.50$2.65M8,753,290Aug 8, 2025Aug 12, 2025View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
17,95069,777Jan 31, 2025Feb 4, 2025View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
35,90035,900Jan 31, 2025Feb 4, 2025View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
35,900$1.73$62.1K35,900Jan 30, 2025Feb 3, 2025View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
17,95069,777Jan 30, 2025Feb 3, 2025View →
JSPR
JASPER THERAPEUTICS, INC.
PURCHASE
350,000$12.95$4.53M1,188,500Feb 8, 2024Feb 9, 2024View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
13,94851,827Jan 19, 2024Jan 19, 2024View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
83,68583,685Jan 19, 2024Jan 19, 2024View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
2,486,744$1.37$3.41M6,986,744Jul 21, 2023Jul 25, 2023View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASE
1,162,891$1.37$1.59M1,162,891Jul 21, 2023Jul 25, 2023View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
227,272227,272Feb 22, 2023Feb 24, 2023View →
HRTX
HERON THERAPEUTICS, INC. /DE/
PURCHASEGRANT
Stock grant
37,87937,879Feb 22, 2023Feb 24, 2023View →
Other insiders · HRTX
Loading peer insiders…
About this filer
CIK 0001964335
ROLE
Director
PRIMARY
HRTX
COMPANIES
2
ACTIVE SINCE
Feb 2023
MARKETPEEL · /INSIDER/0001964335DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback